Klebsiella oxytoca
Report Name: 2003 Klebsiella oxytoca
Query Selection Criteria:
Report Start Date: 01/01/2003 (MM/DD/YYYY)
Report End Date: 12/31/2003 (MM/DD/YYYY)
Organism: Klebsiella oxytoca
Drug: Amikacin;Ampicillin;Cefazolin;Cefepime;Cefotaxime;Ceftazidime;Ce
ftriaxone;Ciprofloxacin;Colistin;Gentamicin;Imipenem;Nitrofurantoi
n;Piperacillin;Piperacillin/tazobactam;Tobramycin;Trimeth/sulfa
Breakpoint: NCCLS
Patient Type: Inpatient;Inpatient - ICU
Patient Age: greater than or equal to 18 AND less than or equal to 120
Institution: T84 University of CA at San Francisco - Parnassus
Street-ALL;T84 Mt. Zion Medical Center - Divisedero Street
Trending: None
Dataset: Institution
Chosen Country: United States
Source: TSN Database
Copyright 2004 Focus Technologies, Inc.
Organism Klebsiella oxytoca S S I I R R
Drug Total N % N % N %
Amikacin 33 33 100.0 % 0 0.0 % 0 0.0 %
Ampicillin 33 1 3.0 % 1 3.0 % 31 93.9 %
Cefazolin 33 19 57.6 % 5 15.2 % 9 27.3 %
Cefepime 33 32 97.0 % 1 3.0 % 0 0.0 %
Cefotaxime 33 32 97.0 % 0 0.0 % 1 3.0 %
Ceftazidime 33 32 97.0 % 0 0.0 % 1 3.0 %
Ceftriaxone 33 32 97.0 % 0 0.0 % 1 3.0 %
Ciprofloxacin 33 32 97.0 % 0 0.0 % 1 3.0 %
Colistin 0 0 N/A 0 N/A 0 N/A
Gentamicin 33 30 90.9 % 0 0.0 % 3 9.1 %
Imipenem 33 33 100.0 % 0 0.0 % 0 0.0 %
Nitrofurantoin 17 17 100.0 % 0 0.0 % 0 0.0 %
Piperacillin 19 15 78.9 % 1 5.3 % 3 15.8 %
Piperacillin/tazobactam 33 30 90.9 % 1 3.0 % 2 6.1 %
Tobramycin 33 32 97.0 % 0 0.0 % 1 3.0 %
Trimeth/sulfa 33 23 69.7 % 0 0.0 % 10 30.3 %
For agents with >25% of strains tested:
Plain=<60% activity